Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
oleoylestrone (1 trial)
Aggression (Phase 2)
Alzheimer Disease (Phase 2)
Dementia (Phase 2)
Mental Disorders (Phase 2)
Psychomotor Agitation (Phase 2)
Psychotic Disorders (Phase 2)
Trials (1 total)
Trial APIs (1 total)